REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.83
+0.07 (0.80%)
Nov 5, 2024, 11:14 AM EST - Market open
REGENXBIO Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 436 | 790 | 982 | 1,399 | 1,697 | 1,511 | |
Market Cap Growth | -33.67% | -19.58% | -29.79% | -17.58% | 12.32% | 0.48% | |
Enterprise Value | 264 | 622 | 601 | 1,130 | 1,468 | 1,100 | |
Last Close Price | 8.76 | 17.95 | 22.68 | 32.70 | 45.36 | 40.97 | |
PE Ratio | - | -2.98 | -3.49 | 11.24 | -15.20 | -15.87 | |
PS Ratio | 4.53 | 8.75 | 8.71 | 2.97 | 10.98 | 42.88 | |
PB Ratio | 1.24 | 2.53 | 1.90 | 1.83 | 4.49 | 3.36 | |
P/FCF Ratio | -2.96 | -3.46 | -4.12 | 10.38 | -20.97 | -12.65 | |
P/OCF Ratio | -3.02 | -3.62 | -4.73 | 6.39 | -31.39 | -14.03 | |
EV/Sales Ratio | 2.97 | 6.89 | 5.33 | 2.40 | 9.50 | 31.23 | |
EV/EBITDA Ratio | -1.62 | -2.52 | -2.57 | 6.67 | -13.25 | -7.76 | |
EV/EBIT Ratio | -1.51 | -2.35 | -2.44 | 7.06 | -12.31 | -7.39 | |
EV/FCF Ratio | -1.88 | -2.72 | -2.52 | 8.39 | -18.14 | -9.21 | |
Debt / Equity Ratio | 0.46 | 0.59 | 0.45 | 0.34 | 0.70 | 0.03 | |
Debt / EBITDA Ratio | - | - | - | 1.42 | - | - | |
Debt / FCF Ratio | -0.82 | -0.80 | -0.98 | 1.92 | -3.29 | -0.09 | |
Asset Turnover | 0.14 | 0.13 | 0.12 | 0.52 | 0.26 | 0.07 | |
Quick Ratio | 3.41 | 2.45 | 3.08 | 3.72 | 6.37 | 9.93 | |
Current Ratio | 3.53 | 2.57 | 3.19 | 3.98 | 6.52 | 10.25 | |
Return on Equity (ROE) | -63.94% | -63.65% | -43.78% | 22.39% | -26.87% | -19.76% | |
Return on Assets (ROA) | -24.26% | -23.49% | -15.80% | 10.98% | -12.36% | -17.88% | |
Return on Capital (ROIC) | -27.10% | -26.58% | -17.38% | 12.00% | -13.49% | -19.08% | |
Earnings Yield | -55.68% | -33.37% | -28.55% | 9.14% | -6.56% | -6.27% | |
FCF Yield | -44.97% | -28.92% | -24.26% | 9.63% | -4.77% | -7.91% | |
Buyback Yield / Dilution | -6.20% | -1.35% | 1.73% | -17.79% | -1.61% | -0.11% | |
Total Shareholder Return | -6.20% | -1.35% | 1.73% | -17.79% | -1.61% | -0.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.